Bharat Biotech commences direct supply of Covaxin to 14 states
Bharat Biotech has commenced direct
supply of its COVID-19 vaccine 'Covaxin' to 14 states,
including Delhi and Maharashtra, with effect from May 1, according to the
company's Joint Managing Director Suchitra Ella.
The
Hyderabad-based firm has started supplying its COVID-19 treatment vaccine to
the states based on the allocations received by the central government.
"Bharat
Biotech confirms direct supplies of COVAXIN
to the following state govt's since 1/5/21, based on the allocations received
by GoI. Requests have been received from other states, & will be processed
for distribution based on availability of stocks 24x7," Ella tweeted.
The
company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat,
Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana,
Uttar Pradesh and West Bengal. Read More
Comments
Post a Comment